Xiaolan Su
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- RNA modifications and cancer 8
- Epigenetics and DNA Methylation 5
- RNA Interference and Gene Delivery 4
- Angiogenesis and VEGF in Cancer 3
- Oncology 14
- Cytokine Signaling Pathways and Interactions 3
- Cancer Cells and Metastasis 3
- Co-authors
- Yuquan Wei (15 shared papers)Lei Dai (21 shared papers)Hongxin Deng (21 shared papers)Lin Cheng (12 shared papers)Gang Shi (13 shared papers)Yuqin Yao (9 shared papers)Shuang Zhang (7 shared papers)Xinmei Luo (5 shared papers)
- Journals
- Oncotarget (2 papers)Stem Cell Research & Therapy (2 papers)Biomaterials (2 papers)Journal of Cancer Research and Clinical Oncology (2 papers)Mucosal Immunology (2 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Xiaolan Su
43 papers receiving 906 citations
Peers
Comparison fields: 5 of 91
- Cancer Research 221
- Immunology 192
- Oncology 218
- Molecular Biology 491
- Biomaterials 79
Countries citing papers authored by Xiaolan Su
This map shows the geographic impact of Xiaolan Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolan Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolan Su more than expected).
Fields of papers citing papers by Xiaolan Su
This network shows the impact of papers produced by Xiaolan Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolan Su. The network helps show where Xiaolan Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaolan Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 87 | |
| 2 | 2014 | 76 | |
| 3 | 2017 | 60 | |
| 4 | 2012 | 44 | |
| 5 | 2016 | 37 | |
| 6 | 2017 | 37 | |
| 7 | 2015 | 34 | |
| 8 | 2015 | 32 | |
| 9 | 2017 | 32 | |
| 10 | 2020 | 29 | |
| 11 | 2019 | 26 | |
| 12 | 2020 | 25 | |
| 13 | 2018 | 25 | |
| 14 | 2022 | 22 | |
| 15 | 2018 | 21 | |
| 16 | 2012 | 21 | |
| 17 | 2012 | 20 | |
| 18 | 2019 | 19 | |
| 19 | 2019 | 19 | |
| 20 | 2012 | 18 |
About Xiaolan Su
Xiaolan Su is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Surgery, having authored 44 papers that have together received 916 indexed citations. Recurring topics across this work include RNA modifications and cancer (8 papers), Epigenetics and DNA Methylation (5 papers), RNA Interference and Gene Delivery (4 papers), MicroRNA in disease regulation (4 papers), Cytokine Signaling Pathways and Interactions (3 papers), Cancer Cells and Metastasis (3 papers), Cancer-related molecular mechanisms research (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). The work is most often cited by research in Cancer Research (221 citations), Immunology (192 citations), Oncology (218 citations), Molecular Biology (491 citations) and Biomaterials (79 citations). Xiaolan Su has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Yuquan Wei, Lei Dai, Hongxin Deng, Lin Cheng, Gang Shi, Yuqin Yao, Shuang Zhang, Xinmei Luo, Xiaolei Chen and Qianqian Jiang. Their work appears in journals such as Oncotarget, Stem Cell Research & Therapy, Biomaterials, Journal of Cancer Research and Clinical Oncology and Mucosal Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.